Official File: Biotech Data Scientist Postdoc – Job Posting The Kuhn-Hicks laboratory at USC is a leader in mathematical oncology for predictive mapping of cancer progression and treatment response. The laboratory uses clinical, demographic, and single cell morpho-proteo-genomic data to build predictive models to aid in improving patient care and outcomes. Our rapidly growing team is... Read More
While literature in clinical practice and patient rights suggests that study participants should have access to their genomic data, IRBs do not currently include mechanisms to facilitate effective and ethical collection of patient data across institutions and dissemination back to patients. Professor Kuhn and colleagues discuss the rights of patients to access their genomic data and... Read More
In this feature story, Professor Kuhn shares his personal journey of how his mother’s diagnosis drove him to leave physics and tackle the challenges facing cancer biomedicine. He now leads the Convergent Science Initiative in Cancer (CSI-Cancer) at the USC Michelson Center for Convergent Bioscience where cutting-edge tools are being developed to improve outcomes for... Read More
New research projects at the Kuhn-Hicks laboratory aim to develop computational technologies to map cancer evolution and predict treatment response. Through collaboration with the FDA on breast cancer) and funding by the Adelson Medical Research Foundation for multiple myeloma, the goal of these projects is to deploy novel machine learning and spatiotemporal models that would assist clinicians... Read More
A recent article in The Guardian highlights research from our lab on how fitness technologies are being used to monitor and predict how patients respond to chemotherapy. Led by Keck School of Medicine’s Dr Jorge Nieva, our clinical collaborator, the work emphasizes the efforts to use fitness trackers as objective measures for patient’s quality of... Read More
The Kuhn-Hicks laboratory are using metal-tagged antibodies to map the proteins expressed on cancer cells circulating in the blood and in the bone marrow from a prostate cancer patient. The study, published in January by Convergent Science Physical Oncology, describes the approach of using an imaging mass cytometer to quantitate and localize 35 different protein markers... Read More
A new publication from Dr. James Hicks describing the utility of single-cell genomics from prostate biopsies towards improving diagnosis and prognosis in prostate cancer. See the Cancer Research article here.
The Kuhn and Hicks Laboratory at the USC Michelson Center for Convergent Bioscience (Los Angeles, CA) is looking for three postdoctoral fellows to focus on specific single cell and liquid biopsy projects in breast, lung and prostate cancer. Critical to being a successful candidate are the determination to improving outcomes for cancer patients through scientific... Read More
USC’s Convergent Science Initiative in Cancer and the USC Jimmy Iovine and Andre Young Academy have developed a new interdisciplinary undergraduate track to launch in the fall of 2019. Students in this new educational track will interact with physicians, scientists, patients and graduate students to develop innovative health solutions. Click here to read more.
Dr. Peter Kuhn and Dr. Valery Folkin of the USC Michelson Center for Convergent Bioscience discuss the role of the new Michelson Center building and a supportive culture in encouraging interdisciplinary collaboration. Click here to read more.